Pancreatic cancer stem cells

Journal of Clinical Oncology

Volumn 26, Issue 17, 2008, Pages 2806-2812

  Lee, Cheong J ^a   Dosch, Joseph ^a   Simeone, Diane M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; CD24 ANTIGEN; CELL SURFACE MARKER; FLUOROURACIL; GEMCITABINE; HERMES ANTIGEN; IMATINIB; OXALIPLATIN; SONIC HEDGEHOG PROTEIN; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANTIGEN EXPRESSION; BRAIN TUMOR; BREAST TUMOR; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL RENEWAL; CELL SUBPOPULATION; CELL SURVIVAL; COLON TUMOR; HUMAN; INFLAMMATION; LEUKEMIA; METASTASIS; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROSTATE TUMOR; REVIEW; SKIN TUMOR; UPREGULATION; ANIMAL; CELL PROLIFERATION; CELL SEPARATION; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; RADIATION EXPOSURE; RADIOTHERAPY; REGENERATION; SIGNAL TRANSDUCTION; TREATMENT FAILURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; RADIOTHERAPY; REGENERATION; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 45549100014     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.6702     Document Type: Review

References (47)

1. Jemal A, Siegel R, Ward E, et al: Cancer Statistics, 2007 CA Cancer J Clin 57:43-66, 2007
2. Hezel AF, Kimmelman AC, Stanger BZ, et al: Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20:1218-1249, 2006
3. Niederhuber JE, Brennen MF, Manck HR: The National Cancer Data Base Report on pancreatic cancer. Cancer 76:1671-1677, 1995
4. Reya T, Morrison SJ, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature 414:105-111, 2001
5. Bissell MJ, Labarge MA: Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17-23, 2005
6. McDonald JW, Liu XZ, Qu Y, et al: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med 5:1410-1412, 1999
7. Huntly BJ, Shigematsu H, Deguchi K, et al: MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6:587-596, 2004
8. Jamieson CH, Ailles LE, Dylla SJ, et al: Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351:657-667, 2004
9. Guerra C, Schuhmacher AJ, Canamero M, et al: Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11:291-302, 2007
10. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3:730-737, 1997
11. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988, 2003
12. Krivtsov AV, Twomey D, Feng Z, et al: Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442:818-822, 2006
13. Ponta H, Sherman L, Herrlich PA: CD44: From adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4:33-45, 2003
14. Weichert W, Denkert C, Burkhardt M, et al: Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11:6574-6581, 2005
15. Jin L, Hope KJ, Zhai Q, et al: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Med 12:1167-1174, 2006
16. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037, 2007
17. O'Brien CA, Pollett A, Gallinger S, et al: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110, 2007
18. Ricci-Vitiani L, Lombardi DG, Pillozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115, 2007
19. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumor initiating cells. Nature 432:396-401, 2004
20. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323, 2007
21. Wright MH, Calcagno AM, Salcido CD, et al: BRCA1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10:R10, 2008
22. Ishibashi S, Sakaguchi M, Kuroiwa T, et al: Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res 78:215-223, 2004
23. Huang EH, Heidt DG, Li C, et al: Cancer stem cells: A new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141:415-419, 2007
24. Clement V, Sanchez P, de Tribolet N, et al: Hedgehog-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165-172, 2007
25. Lessard J, Sauvageau G: BMI-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260, 2003
26. Dontu G, Jackson KW, McNicholas E, et al: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6:R605-R615, 2004
27. Liu S, Dontu G, Mantle ID, et al: Hedgehog signaling and BMI-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071, 2006
28. Yilmaz OH, Valdez R, Theisen BK, et al: PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475-482, 2006
29. Berman DM, Karhadkar SS, Maitra A, et al: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846-851, 2003
30. Thayer SP, di Magliano MP, Heiser PW, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856, 2003
31. Cui H, Hu B, Li T, et al: BMI-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 170:1370-1378, 2007
32. Lowenfels A, Maisonneuve P, DiMagno E, et al: Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 89:442-446, 1997
33. Lowenfels AB, Maisonneuve P, Cavallini G, et al: Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group. N Engl J Med 328:1433-1437, 1993
34. Narducci MG, Scala E, Bresin A, et al: Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 107:1108-1115, 2006
35. Klein RS, Rubin JB, Gibson HD, et al: SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 128:1971-1981, 2001
36. Doitsidou M, Reichman-Fried M, Stebler J, et al: Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 111:647-659, 2002
37. Aiuti A, Webb IJ, Bleul C, et al: The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111-120, 1997
38. Michor F, Hughes TP, Iwasa Y, et al: Dynamics of chronic myeloid leukaemia. Nature 435:1267-1270, 2005
39. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760, 2006
40. Todaro M, Alea Mp, Stefano AB, et al: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1:389-402, 2007
41. Shah AN, Summy JM, Zhang J, et al: Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14:3629-3637, 2007
42. Chen MS, Woodward WA, Behbod F, et al: Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 120:468-477, 2007
43. Woodward WA, Chen MS, Behbod F, et al: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 104:618-623, 2007
44. Ayyanan A, Civenni G, Ciarloni L, et al: Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 103:3799-3804, 2006
45. Asanuma K, Moriai R, Yajima T, et al: Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91:1204-1209, 2000
46. Phillips TM, McBride WH, Pajonk F: The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777-1785, 2006
47. Mungamuri SK, Yang X, Thor AD, et al: Survival signaling by notch1: Mammalian target of reapamycin (mTOR)-dependent inhibition of p53. Cancer Res 66:4715-4724, 2006